Flecainide, an antiarrhythmic medication, is manufactured by several pharmaceutical companies globally. The specific country of origin can vary depending on the manufacturer and the product's distribution.
Who Manufactures Flecainide?
Multiple companies produce flecainide, including generics. Some of the key manufacturers and their product names include:
* Aurobindo Pharma (USA) manufactures flecainide acetate tablets [1].
* Teva Pharmaceuticals produces flecainide acetate [2].
* Viatris, formed by the merger of Mylan and Upjohn, also has flecainide products [3].
* Hikma Pharmaceuticals is another producer of flecainide acetate tablets [4].
* Amneal Pharmaceuticals offers flecainide acetate [5].
The manufacturing locations for these companies are diverse, with production facilities spread across different continents to serve global markets.
What are the Common Formulations of Flecainide?
Flecainide is most commonly available in oral tablet form, typically as flecainide acetate. These tablets are prescribed to treat certain types of irregular heartbeats, such as atrial fibrillation and supraventricular tachycardia. The dosage and specific formulation can vary by manufacturer.
Where Can I Find Information on Flecainide Patents?
Information regarding patents for flecainide and its manufacturing processes can be found on specialized intellectual property databases. Websites like DrugPatentWatch.com track patent information for pharmaceuticals, which can indicate the original patent holders and potential expiry dates for market exclusivity [6]. This is relevant for understanding when generic versions may become more widely available or if new formulations are being developed.